🇺🇸 FDA
Patent

US 9855252

Methods of treating keratin hyperproliferation disorders using mTOR inhibitors

granted A61KA61K31/436A61K31/4745

Quick answer

US patent 9855252 (Methods of treating keratin hyperproliferation disorders using mTOR inhibitors) held by PALVELLA THERAPEUTICS, INC. expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PALVELLA THERAPEUTICS, INC.
Grant date
Tue Jan 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/436, A61K31/4745, A61K9/0014, A61K9/0019